Assessing Health-Related Quality of Life, Morbidity, and Survival Status for Individuals With Down Syndrome in Pakistan (DS-Pak): Protocol for a Web-Based Collaborative Registry.

Down syndrome health-related quality of life lower-middle income country mobile health patient-reported outcome registry web-based registry

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
03 Jun 2021
Historique:
received: 09 10 2020
accepted: 09 03 2021
revised: 09 02 2021
entrez: 3 6 2021
pubmed: 4 6 2021
medline: 4 6 2021
Statut: epublish

Résumé

Down syndrome is the most common chromosomal disorder, with a global incidence of 1 in 700 live births. However, the true prevalence, associated morbidities, and health-related quality of life (HRQOL) of these individuals and their families are not well documented, especially in low- and middle-income countries such as Pakistan. Disease-specific documentation in the form of a collaborative registry is required to better understand this condition and the associated health outcomes. This protocol paper describes the aims and processes for developing the first comprehensive, web-based collaborative registry for Down syndrome in a Pakistani cohort. This study aims to assess the HRQOL, long-term survival, and morbidity of individuals with Down syndrome by using a web-based collaborative registry. The registry data collection will be conducted at the Aga Khan University Hospital and at the Karachi Down Syndrome Program. Data will be collected by in-person interviews or virtually via telephone or video interviews. Participants of any age and sex with Down syndrome (trisomy 21) will be recruited. After receiving informed consent and assent, a series of tablet-based questionnaires will be administered. The questionnaires aim to assess the sociodemographic background, clinical status, and HRQOL of the participants and their families. Data will be uploaded to a secure cloud server to allow for real-time access to participant responses by the clinicians to plan prompt interventions. Patient safety and confidentiality will be maintained by using multilayer encryption and unique coded patient identifiers. The collected data will be analyzed using IBM SPSS Statistics for Windows, Version 22.0 (IBM Corporation), with the mean and SD of continuous variables being reported. Categorical variables will be analyzed with their percentages being reported and with a P value cutoff of .05. Multivariate regression analysis will be conducted to identify predictors related to the HRQOL in patients with Down syndrome. Survival analysis will be reported using the Kaplan-Meier survival curves. The web-based questionnaire is currently being finalized before the commencement of pilot testing. This project has not received funding at the moment (ethical review committee approval reference ID: 2020-3582-11145). This registry will allow for a comprehensive understanding of Down syndrome in low- and middle-income countries. This can provide the opportunity for data-informed interventions, which are tailored to the specific needs of this patient population and their families. Although this web-based registry is a proof of concept, it has the potential to be expanded to national, regional, and international levels. PRR1-10.2196/24901.

Sections du résumé

BACKGROUND BACKGROUND
Down syndrome is the most common chromosomal disorder, with a global incidence of 1 in 700 live births. However, the true prevalence, associated morbidities, and health-related quality of life (HRQOL) of these individuals and their families are not well documented, especially in low- and middle-income countries such as Pakistan. Disease-specific documentation in the form of a collaborative registry is required to better understand this condition and the associated health outcomes. This protocol paper describes the aims and processes for developing the first comprehensive, web-based collaborative registry for Down syndrome in a Pakistani cohort.
OBJECTIVE OBJECTIVE
This study aims to assess the HRQOL, long-term survival, and morbidity of individuals with Down syndrome by using a web-based collaborative registry.
METHODS METHODS
The registry data collection will be conducted at the Aga Khan University Hospital and at the Karachi Down Syndrome Program. Data will be collected by in-person interviews or virtually via telephone or video interviews. Participants of any age and sex with Down syndrome (trisomy 21) will be recruited. After receiving informed consent and assent, a series of tablet-based questionnaires will be administered. The questionnaires aim to assess the sociodemographic background, clinical status, and HRQOL of the participants and their families. Data will be uploaded to a secure cloud server to allow for real-time access to participant responses by the clinicians to plan prompt interventions. Patient safety and confidentiality will be maintained by using multilayer encryption and unique coded patient identifiers. The collected data will be analyzed using IBM SPSS Statistics for Windows, Version 22.0 (IBM Corporation), with the mean and SD of continuous variables being reported. Categorical variables will be analyzed with their percentages being reported and with a P value cutoff of .05. Multivariate regression analysis will be conducted to identify predictors related to the HRQOL in patients with Down syndrome. Survival analysis will be reported using the Kaplan-Meier survival curves.
RESULTS RESULTS
The web-based questionnaire is currently being finalized before the commencement of pilot testing. This project has not received funding at the moment (ethical review committee approval reference ID: 2020-3582-11145).
CONCLUSIONS CONCLUSIONS
This registry will allow for a comprehensive understanding of Down syndrome in low- and middle-income countries. This can provide the opportunity for data-informed interventions, which are tailored to the specific needs of this patient population and their families. Although this web-based registry is a proof of concept, it has the potential to be expanded to national, regional, and international levels.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
PRR1-10.2196/24901.

Identifiants

pubmed: 34081014
pii: v10i6e24901
doi: 10.2196/24901
pmc: PMC8212620
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e24901

Informations de copyright

©Ayat Siddiqui, Laila Akbar Ladak, Abdul Momin Kazi, Sidra Kaleem, Fizza Akbar, Salman Kirmani. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 03.06.2021.

Références

Expert Rev Pharmacoecon Outcomes Res. 2005 Dec;5(6):705-19
pubmed: 19807613
Eur J Public Health. 2007 Apr;17(2):221-5
pubmed: 16857692
J Community Genet. 2015 Jan;6(1):47-53
pubmed: 25081228
Lancet Neurol. 2010 Jun;9(6):623-33
pubmed: 20494326
J Pediatr. 2018 Feb;193:9-10
pubmed: 29212622
J Surg Res. 2018 Mar;223:72-86
pubmed: 29433888
Acta Paediatr. 2005 Jun;94(6):769-74
pubmed: 16188785
Ann Thorac Surg. 2019 Jul;108(1):274-282
pubmed: 30742816
J Dev Behav Pediatr. 2014 Apr;35(3):234
pubmed: 24695123
PLoS One. 2018 Jun 13;13(6):e0197394
pubmed: 29897903
Mater Sociomed. 2020 Jun;32(2):93-98
pubmed: 32843854
Pediatrics. 2011 Aug;128(2):393-406
pubmed: 21788214
Dev Med Child Neurol. 2018 Apr;60(4):402-408
pubmed: 29359801
Iran J Public Health. 2013 Sep;42(9):996-1006
pubmed: 26060660
J Speech Lang Hear Res. 2013 Feb;56(1):178-210
pubmed: 23275397
PLoS One. 2020 Dec 31;15(12):e0244989
pubmed: 33382834
J Community Genet. 2013 Jan;4(1):107-14
pubmed: 23090504
Res Dev Disabil. 2013 Nov;34(11):4239-47
pubmed: 24083990
J Pediatr. 2017 Oct;189:98-104.e1
pubmed: 28751125
Injury. 2018 Dec;49(12):2100-2110
pubmed: 30333086
J Intellect Disabil Res. 2011 Aug;55(8):801-20
pubmed: 21668802
J Pediatr. 2018 Feb;193:27-33.e2
pubmed: 29174076
J Pediatr Rehabil Med. 2020;13(3):233-240
pubmed: 32716332
Am J Med Genet A. 2017 Jun;173(6):1539-1545
pubmed: 28332275
Adv Ther. 2017 Aug;34(8):2058-2069
pubmed: 28795347
Cardiol Young. 2020 Aug;30(8):1126-1137
pubmed: 32633708

Auteurs

Ayat Siddiqui (A)

Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.

Laila Akbar Ladak (LA)

Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.
Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, Sydney Nursing School, The University of Sydney, Sydney, Australia.

Abdul Momin Kazi (AM)

Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.

Sidra Kaleem (S)

Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.

Fizza Akbar (F)

Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.

Salman Kirmani (S)

Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.

Classifications MeSH